To help stakeholders better understand our value creation story, we have launched the Sustainability Booklet.
As sustainability-related disclosures continue to expand across multiple reporting channels, including the Annual Securities Report, we reviewed how best to provide information in a clear, accessible, and meaningful way while reducing duplication across disclosures. As a result, we refreshed our former integrated reporting approach and introduced the Sustainability Booklet beginning in FY2026.
The booklet highlights the social value we aim to create through science and innovation, together with the strategies and initiatives that support long-term value creation. It provides a concise overview of our sustainability journey, with links to additional information throughout our website for readers who wish to explore topics in greater detail.

Sustainability

Sustainability is integral to how we create long-term value for patients, society, and future generations. Guided by the principles of the European Sustainability Reporting Standards (ESRS), we have identified key sustainability topics, including climate change, pollution, and our workforce, patients and healthcare professionals, value chain workers, and responsible business conduct.
This report outlines our governance, material impacts, risks and opportunities (IROs), as well as the policies, actions, and progress associated with each topic.

ESG data and Third-Party Assurance

We have identified three social value outcomes that reflect the value it seeks to create through our 5-Year Business Plan (FY2026–FY2030): improving the well-being of cancer patients, creating hope for patients and their families, and creating value for diverse stakeholders.
To measure progress toward these outcomes, we have established a set of outcome indicators. These indicators help visualize the social value generated through our business activities and provide transparency on our progress toward delivering long-term value for patients, society, and other stakeholders.